It is suggested that patients with high CD8+ Tex-SPRY1 cell infiltration have a higher sensitivity to nCIT and that CD8+ Tex-SPRY1 may be a potential biomarker for nCIT in ESCC. This evidence concerns the gene CD8A and esophageal squamous cell carcinoma.